Nature Outlook

Fresh treatments shift the focus from symptom management to repair.

Circulating biomarkers are quickly becoming a crucial part of diagnosis and disease monitoring for physicians, researchers — and even some consumers.

Pain is defined subjectively, but an objective measure of the experience promises to transform its management.

Joining a drug candidate to a protein that malignant cells naturally take up allowed one firm to come up with a potent anti-cancer therapy.

Climate change could intensify the role of this vital and strategic asset in armed conflict.

Drugs that counter RSV infection can safeguard newborns, offering another mode of protection alongside vaccines.

The immunotherapy is beginning to show promise in solid tumours, but researchers want more dedicated research in young people.

Drugs under development offer the mental-health benefits of psilocybin and similar substances without inducing strong hallucinatory effects.

Finite courses of treatment could get the virus under control — with the right combination of drugs.